Midodrine
Tetraplegia
James J. Peters Veterans Affairs Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Tetraplegia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Recombinant Human Plasminogen Activator Rabin Medical Center | Phase 2 | CCC |
Same molecule, other indications
Midodrine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →